Roche’s SARS-CoV-2 test for people not experiencing symptoms received an emergency use authorization from the U.S. FDA, the company announced Tuesday, upholding federal guidance to expand diagnostic tools to tamp down asymptomatic spread.
Roche’s SARS-CoV-2 test for people not experiencing symptoms received an emergency use authorization from the U.S. FDA, the company announced Tuesday, upholding federal guidance to expand diagnostic tools to tamp down asymptomatic spread.
